FAM209B
gene geneOn this page
Also known as dJ1153D9.4
Summary
FAM209B (family with sequence similarity 209 member B, HGNC:16101) is a protein-coding gene on chromosome 20q13.31, encoding Protein FAM209B (Q5JX69). May play a role in sperm acrosome biogenesis.
Predicted to be involved in acrosome assembly. Located in acrosomal vesicle.
Source: NCBI Gene 388799 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 12 total
- MANE Select transcript:
NM_001013646
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16101 |
| Approved symbol | FAM209B |
| Name | family with sequence similarity 209 member B |
| Location | 20q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | dJ1153D9.4 |
| Ensembl gene | ENSG00000213714 |
| Ensembl biotype | protein_coding |
| Entrez | 388799 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000371325
RefSeq mRNA: 1 — MANE Select: NM_001013646
NM_001013646
CCDS: CCDS33494
Canonical transcript exons
ENST00000371325 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000845716 | 56536172 | 56536520 |
| ENSE00001768052 | 56533246 | 56533590 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 96.76.
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 96.76 | gold quality |
| left testis | UBERON:0004533 | 96.68 | gold quality |
| right testis | UBERON:0004534 | 96.20 | gold quality |
| testis | UBERON:0000473 | 93.55 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.50 | gold quality |
| adult organism | UBERON:0007023 | 90.85 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.74 | gold quality |
| blood | UBERON:0000178 | 73.49 | gold quality |
| granulocyte | CL:0000094 | 71.12 | gold quality |
| tibialis anterior | UBERON:0001385 | 67.70 | silver quality |
| spleen | UBERON:0002106 | 67.23 | gold quality |
| leukocyte | CL:0000738 | 67.03 | gold quality |
| monocyte | CL:0000576 | 66.82 | gold quality |
| apex of heart | UBERON:0002098 | 64.78 | gold quality |
| skin of leg | UBERON:0001511 | 63.85 | gold quality |
| gastrocnemius | UBERON:0001388 | 62.45 | gold quality |
| ileal mucosa | UBERON:0000331 | 62.17 | silver quality |
| muscle of leg | UBERON:0001383 | 61.47 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 61.24 | gold quality |
| endothelial cell | CL:0000115 | 61.20 | gold quality |
| skin of abdomen | UBERON:0001416 | 61.05 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 60.97 | gold quality |
| zone of skin | UBERON:0000014 | 60.05 | gold quality |
| pancreatic ductal cell | CL:0002079 | 60.00 | silver quality |
| mucosa of stomach | UBERON:0001199 | 59.96 | gold quality |
| buccal mucosa cell | CL:0002336 | 59.63 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 59.41 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 59.34 | gold quality |
| lymph node | UBERON:0000029 | 59.23 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 58.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.06 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Fam209 | ENSMUSG00000027505 |
| rattus_norvegicus | Fam209 | ENSRNOG00000005235 |
Paralogs (1): FAM209A (ENSG00000124103)
Protein
Protein identifiers
Protein FAM209B — Q5JX69 (reviewed: Q5JX69)
All UniProt accessions (1): Q5JX69
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in sperm acrosome biogenesis.
Subcellular location. Nucleus inner membrane. Cytoplasmic vesicle. Secretory vesicle. Acrosome.
Miscellaneous. The primate lineage appears to have undergone gene duplication of FAM209, such that humans contain FAM209A and FAM209B.
Similarity. Belongs to the FAM209 family.
RefSeq proteins (1): NP_001013668* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027943 | FAM209 | Family |
Pfam: PF15206
UniProt features (9 total): sequence variant 3, topological domain 2, signal peptide 1, chain 1, transmembrane region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JX69-F1 | 58.41 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 27 (showing top):
GOCC_SECRETORY_GRANULE, GOBP_MALE_GAMETE_GENERATION, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOCC_NUCLEAR_ENVELOPE, GOCC_SECRETORY_VESICLE, GOCC_ORGANELLE_INNER_MEMBRANE, GOCC_NUCLEAR_INNER_MEMBRANE, GOCC_ACROSOMAL_VESICLE, GOCC_NUCLEAR_MEMBRANE, NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON, DODD_NASOPHARYNGEAL_CARCINOMA_DN, GOCC_ORGANELLE_ENVELOPE, GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP, DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS, NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN
GO Biological Process (2): spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (0):
GO Cellular Component (5): acrosomal vesicle (GO:0001669), nucleus (GO:0005634), nuclear inner membrane (GO:0005637), membrane (GO:0016020), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| secretory granule | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| nuclear membrane | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
216 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FAM209B | FMR1NB | Q8N0W7 | 511 |
| FAM209B | BCAS4 | Q8TDM0 | 450 |
| FAM209B | PDHA2 | P29803 | 446 |
| FAM209B | PHACTR3 | Q96KR7 | 438 |
| FAM209B | RAB2B | Q8WUD1 | 417 |
| FAM209B | ATP5F1E | P56381 | 379 |
| FAM209B | TULP2 | O00295 | 348 |
| FAM209B | PKDREJ | Q9NTG1 | 348 |
| FAM209B | ZFAND4 | Q86XD8 | 348 |
| FAM209B | MAGEB16 | A2A368 | 347 |
| FAM209B | TMCO5A | Q8N6Q1 | 343 |
| FAM209B | CATSPER1 | Q8NEC5 | 339 |
| FAM209B | SPATA16 | Q9BXB7 | 333 |
| FAM209B | ATP5F1D | P30049 | 323 |
| FAM209B | SLC25A3 | Q00325 | 323 |
| FAM209B | ATP5PD | O75947 | 323 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A096P2H6, A0A0D9S1R4, A2APA5, A9CBA0, P06740, P06759, P0DKU6, P0DKW1, P0DKW2, P0DKW3, P0DKW4, P0DKY3, P0DML4, P0DML5, P0DML6, P0DMN8, P0DOC4, P0DP53, P0DTG9, P0DTH0, P0DTH1, P0DTH2, P0DTH3, P0DTH4, P0DUP5, P0DUP6, P22749, P33622, P35225, P55056, P55057, P55797, Q0VCT2, Q13790, Q3SYR5, Q3ZRW9, Q5HZE8, Q5JTB6, Q5JX69, Q5JX71
Diamond homologs: A2APA5, Q5JX69, Q5JX71
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
12 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
92 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:56533588:AAGG:A | donor_loss | 0.9900 |
| 20:56533590:GGTA:G | donor_loss | 0.9900 |
| 20:56533591:G:C | donor_loss | 0.9900 |
| 20:56533591:G:GG | donor_gain | 0.9900 |
| 20:56536169:CA:C | acceptor_loss | 0.9900 |
| 20:56536170:A:C | acceptor_loss | 0.9900 |
| 20:56536171:G:GC | acceptor_loss | 0.9900 |
| 20:56536170:A:AG | acceptor_gain | 0.9800 |
| 20:56536171:G:GG | acceptor_gain | 0.9800 |
| 20:56536171:GGA:G | acceptor_gain | 0.9700 |
| 20:56536171:GGAGC:G | acceptor_gain | 0.9600 |
| 20:56536166:T:TA | acceptor_gain | 0.9500 |
| 20:56533589:AG:A | donor_gain | 0.9200 |
| 20:56533590:GG:G | donor_gain | 0.9200 |
| 20:56534313:T:G | donor_gain | 0.9200 |
| 20:56534314:G:GG | donor_gain | 0.9100 |
| 20:56536170:AG:A | acceptor_gain | 0.9100 |
| 20:56536171:GG:G | acceptor_gain | 0.9100 |
| 20:56533586:ATAAG:A | donor_gain | 0.8900 |
| 20:56533587:TAAG:T | donor_gain | 0.8900 |
| 20:56534318:GGAGA:G | donor_gain | 0.8900 |
| 20:56536169:CAGG:C | acceptor_gain | 0.8900 |
| 20:56536170:AGGA:A | acceptor_gain | 0.8900 |
| 20:56536171:GGAG:G | acceptor_gain | 0.8900 |
| 20:56534319:G:T | donor_gain | 0.8800 |
| 20:56534330:GT:G | donor_gain | 0.8600 |
| 20:56534404:C:A | donor_gain | 0.8500 |
| 20:56533392:C:G | donor_gain | 0.8400 |
| 20:56536172:G:C | acceptor_gain | 0.8100 |
| 20:56533296:C:T | donor_gain | 0.8000 |
AlphaMissense
1123 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:56533405:T:C | F22L | 0.875 |
| 20:56533407:C:A | F22L | 0.875 |
| 20:56533407:C:G | F22L | 0.875 |
| 20:56533525:T:A | W62R | 0.796 |
| 20:56533525:T:C | W62R | 0.796 |
| 20:56533390:A:C | S17R | 0.795 |
| 20:56533392:C:A | S17R | 0.795 |
| 20:56533392:C:G | S17R | 0.795 |
| 20:56536298:T:C | F126L | 0.777 |
| 20:56536300:T:A | F126L | 0.777 |
| 20:56536300:T:G | F126L | 0.777 |
| 20:56533465:T:C | F42L | 0.753 |
| 20:56533467:T:A | F42L | 0.753 |
| 20:56533467:T:G | F42L | 0.753 |
| 20:56533378:T:C | C13R | 0.734 |
| 20:56533549:T:C | F70L | 0.732 |
| 20:56533551:T:A | F70L | 0.732 |
| 20:56533551:T:G | F70L | 0.732 |
| 20:56536324:A:C | K134N | 0.730 |
| 20:56536324:A:T | K134N | 0.730 |
| 20:56536259:T:C | F113L | 0.692 |
| 20:56536261:C:A | F113L | 0.692 |
| 20:56536261:C:G | F113L | 0.692 |
| 20:56536323:A:T | K134I | 0.683 |
| 20:56533534:T:C | F65L | 0.682 |
| 20:56533536:T:A | F65L | 0.682 |
| 20:56533536:T:G | F65L | 0.682 |
| 20:56533506:G:C | W55C | 0.680 |
| 20:56533506:G:T | W55C | 0.680 |
| 20:56533504:T:A | W55R | 0.673 |
dbSNP variants (sampled 300 via entrez): RS1000155827 (20:56533760 A>T), RS1001317103 (20:56534170 T>C), RS1001602125 (20:56535877 A>G), RS1001827164 (20:56535759 T>C), RS1001950568 (20:56535415 A>T), RS1003627934 (20:56532069 G>A), RS1003680450 (20:56531680 G>A,C), RS1004101423 (20:56533722 G>A,T), RS1004113779 (20:56536450 T>A,C), RS1004625866 (20:56531625 A>G), RS1005241312 (20:56534925 T>G), RS1006101574 (20:56536605 G>A), RS1006621368 (20:56534422 C>G), RS1007704173 (20:56531816 G>T), RS1008026856 (20:56532144 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_730 | Obesity-related traits | 6.000000e-06 |
| GCST009391_1424 | Metabolite levels | 4.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005116 | urinary metabolite measurement |
| EFO:0010452 | adenosine diphosphate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Lead | increases expression | 1 |
| Quercetin | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Copper Sulfate | increases expression | 1 |
| Lactic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.